Molecular and Clinical Investigations in Patients with Low-renin Hypertension

Overview

Journal Clin Exp Nephrol

Publisher Springer

Specialty Nephrology

Date 2008 Aug 16

PMID 18704622

Citations 7

Authors

Isla S Mackenzie

Morris J Brown

Affiliations

Soon will be listed here.

Abstract

Interactions between the renin-angiotensin-aldosterone system and other mechanisms determining sodium balance are important in the pathophysiology of hypertension. Low-renin hypertension is a common type of resistant hypertension and is often associated with increased sodium retention. The importance of investigation, factors determining renin and aldosterone levels, and drug therapies in low-renin hypertension are reviewed.

Citing Articles

Salt Sensitivity of Blood Pressure in Black People: The Need to Sort Out Ancestry Versus Epigenetic Versus Social Determinants of Its Causation.

Elijovich F, Kirabo A, Laffer C Hypertension. 2023; 81(3):456-467.

PMID: 37767696 PMC: 10922075. DOI: 10.1161/HYPERTENSIONAHA.123.17951.

Primary aldosteronism: molecular medicine meets public health.

Azizan E, Drake W, Brown M Nat Rev Nephrol. 2023; 19(12):788-806.

PMID: 37612380 PMC: 7615304. DOI: 10.1038/s41581-023-00753-6.

Effect of Chronically Suppressed Plasma Angiotensin II on Regulation of the CYP4A/20-HETE Pathway in the Dahl Salt-Sensitive Rat.

Lukaszewicz K, Falck J, Lombard J Antioxidants (Basel). 2023; 12(4).

PMID: 37107157 PMC: 10135295. DOI: 10.3390/antiox12040783.

The importance of the epithelial sodium channel in determining salt sensitivity in people of African origin.

Jones E, Rayner B Pediatr Nephrol. 2020; 36(2):237-243.

PMID: 31897716 DOI: 10.1007/s00467-019-04427-z.

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.

Brown M, Williams B, Morant S, Webb D, Caulfield M, Cruickshank J Lancet Diabetes Endocrinol. 2015; 4(2):136-47.

PMID: 26489809 PMC: 4728199. DOI: 10.1016/S2213-8587(15)00377-0.

References

Hood S, Cannon J, Foo R, Brown M . Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing. Clin Med (Lond). 2005; 5(1):55-60. PMC: 4954070. DOI: 10.7861/clinmedicine.5-1-55. View

Hood S, Taylor K, Ashby M, Brown M . The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Circulation. 2007; 116(3):268-75. DOI: 10.1161/CIRCULATIONAHA.107.690396. View

Vierhapper H, Waldhausl W . Reduced pressor effect of angiotensin II and of noradrenaline in normal man following the oral administration of the calcium-antagonist nifedipine. Eur J Clin Invest. 1982; 12(3):263-7. DOI: 10.1111/j.1365-2362.1982.tb01002.x. View

Stewart P, Corrie J, Shackleton C, Edwards C . Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest. 1988; 82(1):340-9. PMC: 303514. DOI: 10.1172/JCI113592. View

WILSON F, Choate K, Ishikawa K, Desitter I, Gunel M, Milford D . Human hypertension caused by mutations in WNK kinases. Science. 2001; 293(5532):1107-12. DOI: 10.1126/science.1062844. View

Stokes G, Monaghan J, Berman K, Ryan M, Campbell D . Double-blind crossover study of the interaction between perindopril and amlodipine on blood pressure and hormones related to fluid and electrolyte balance in patients with essential hypertension. J Hum Hypertens. 1998; 12(2):129-34. DOI: 10.1038/sj.jhh.1000557. View

Burton T, Cope G, Wang J, Sim J, Azizan E, OShaughnessy K . Expression of the epithelial Na(+) channel and other components of an aldosterone response pathway in human adrenocortical cells. Eur J Pharmacol. 2009; 613(1-3):176-81. DOI: 10.1016/j.ejphar.2009.04.005. View

Sutherland D, RUSE J, Laidlaw J . Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J. 1966; 95(22):1109-19. PMC: 1935810. View

Staessen J, Fagard R, Hespel P, Lijnen P, Moerman E, Amery A . Acute calcium entry blockade inhibits the blood pressure but not the hormonal responses to angiotensin II. Eur J Clin Pharmacol. 1989; 36(6):567-73. DOI: 10.1007/BF00637737. View

10.

Gordon R, Stowasser M, Tunny T, Klemm S, Rutherford J . High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol. 1994; 21(4):315-8. DOI: 10.1111/j.1440-1681.1994.tb02519.x. View

11.

Bravo E, TARAZI R, Pohl M, Gifford R, Vidt D . Clinical implications of primary aldosteronism with resistant hypertension. Hypertension. 1988; 11(2 Pt 2):I207-11. DOI: 10.1161/01.hyp.11.2_pt_2.i207. View

12.

Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K . Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R. Eur J Pharmacol. 2008; 584(2-3):424-34. DOI: 10.1016/j.ejphar.2008.02.001. View

13.

Deary A, Schumann A, Murfet H, Haydock S, Foo R, Brown M . Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs. J Hypertens. 2002; 20(4):771-7. DOI: 10.1097/00004872-200204000-00037. View

14.

Elliott H, Pasanisi F, Reid J . Effects of nicardipine on aldosterone release and pressor mechanisms. Br J Clin Pharmacol. 1985; 20 Suppl 1:99S-102S. PMC: 1400791. DOI: 10.1111/j.1365-2125.1985.tb05150.x. View

15.

Dietz J, Du S, Bolten C, Payne M, Xia C, Blinn J . A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. Hypertension. 2008; 51(3):742-8. DOI: 10.1161/HYPERTENSIONAHA.107.103580. View

16.

Brown M, Hopper R . Calcium-channel blockade can mask the diagnosis of Conn's syndrome. Postgrad Med J. 2000; 75(882):235-6. PMC: 1741191. DOI: 10.1136/pgmj.75.882.235. View

17.

Fiad T, Cunningham S, Hayes F, McKenna T . Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis. J Clin Endocrinol Metab. 1997; 82(2):457-60. DOI: 10.1210/jcem.82.2.3748. View

18.

Millar J, Struthers A, Beastall G, Reid J . Effect of nifedipine on blood pressure and adrenocortical responses to trophic stimuli in humans. J Cardiovasc Pharmacol. 1982; 4 Suppl 3:S330-4. View

19.

Williams B, Poulter N, Brown M, Davis M, McInnes G, Potter J . Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004; 18(3):139-85. DOI: 10.1038/sj.jhh.1001683. View

20.

Lim P, Dow E, Brennan G, Jung R, MacDonald T . High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens. 2000; 14(5):311-5. DOI: 10.1038/sj.jhh.1001013. View